The newly discovered interaction between CD9 and TREM2 isoforms raises the prospect that TREM2 isoforms could be playing a role in cell–cell interaction within the same cell type or between different types of cells relevant to brain immunomodulation and, by extension, to AD. Here, TREM2 is linked to Alzheimer disease.